Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma

Hyunsoo Kim, Kyu Yeoun Won, Gou Young Kim, Soo Cheol Kim, Yong Koo Park, Youn Wha Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Raf-1 kinase inhibitory protein (RKIP), a suppressor of metastasis, is associated inversely with the progression and metastasis of human malignancies. The present study evaluated relationships between RKIP expression and metastatic potential, clinicopathological characteristics and patient outcome in esophageal squamous cell carcinoma (ESCC). We examined tissue specimens from 138 patients with thoracic ESCC. Using immunohistochemistry, RKIP expression was detected in ESCC . in situ, primary ESCC and nodal metastatic ESCC. RKIP expression was reduced in 28.9% (13/45) of ESCC . in situ, in 50.0% (69/138) of primary ESCC and in 71.4% (65/91) of nodal metastatic ESCC. These levels of RKIP down-regulation differed significantly. RKIP expression was associated inversely with histological grade (. P=. 0.008), pathological T stage (. P=. 0.044), lymphatic invasion (. P=. 0.019), regional lymph node metastasis (LNM; . P=. 0.002) and stage (. P=. 0.041). Pathological T stage (. P=. 0.001), lymphatic invasion (. P<. 0.001) and reduced RKIP expression (. P=. 0.039) were independent predictors of regional LNM in ESCC. In addition, the postoperative survival of patients with RKIP-reduced ESCC was significantly shorter than for patients with RKIP-positive ESCC (. P=. 0.004). Reduced RKIP expression in ESCC correlated with advanced disease, regional LNM and poor prognosis. RKIP expression may serve as a novel clinical biomarker in patients with ESCC.

Original languageEnglish
Pages (from-to)292-299
Number of pages8
JournalPathology Research and Practice
Volume208
Issue number5
DOIs
Publication statusPublished - 2012 May 15

Fingerprint

Proto-Oncogene Proteins c-raf
Lymph Nodes
Neoplasm Metastasis
Survival
Proteins
Esophageal Squamous Cell Carcinoma
Tumor Suppressor Proteins

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Kim, Hyunsoo ; Won, Kyu Yeoun ; Kim, Gou Young ; Kim, Soo Cheol ; Park, Yong Koo ; Kim, Youn Wha. / Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma. In: Pathology Research and Practice. 2012 ; Vol. 208, No. 5. pp. 292-299.
@article{f1e23cb735314e0bb303f29315d3cd20,
title = "Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma",
abstract = "Raf-1 kinase inhibitory protein (RKIP), a suppressor of metastasis, is associated inversely with the progression and metastasis of human malignancies. The present study evaluated relationships between RKIP expression and metastatic potential, clinicopathological characteristics and patient outcome in esophageal squamous cell carcinoma (ESCC). We examined tissue specimens from 138 patients with thoracic ESCC. Using immunohistochemistry, RKIP expression was detected in ESCC . in situ, primary ESCC and nodal metastatic ESCC. RKIP expression was reduced in 28.9{\%} (13/45) of ESCC . in situ, in 50.0{\%} (69/138) of primary ESCC and in 71.4{\%} (65/91) of nodal metastatic ESCC. These levels of RKIP down-regulation differed significantly. RKIP expression was associated inversely with histological grade (. P=. 0.008), pathological T stage (. P=. 0.044), lymphatic invasion (. P=. 0.019), regional lymph node metastasis (LNM; . P=. 0.002) and stage (. P=. 0.041). Pathological T stage (. P=. 0.001), lymphatic invasion (. P<. 0.001) and reduced RKIP expression (. P=. 0.039) were independent predictors of regional LNM in ESCC. In addition, the postoperative survival of patients with RKIP-reduced ESCC was significantly shorter than for patients with RKIP-positive ESCC (. P=. 0.004). Reduced RKIP expression in ESCC correlated with advanced disease, regional LNM and poor prognosis. RKIP expression may serve as a novel clinical biomarker in patients with ESCC.",
author = "Hyunsoo Kim and Won, {Kyu Yeoun} and Kim, {Gou Young} and Kim, {Soo Cheol} and Park, {Yong Koo} and Kim, {Youn Wha}",
year = "2012",
month = "5",
day = "15",
doi = "10.1016/j.prp.2012.02.011",
language = "English",
volume = "208",
pages = "292--299",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "5",

}

Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma. / Kim, Hyunsoo; Won, Kyu Yeoun; Kim, Gou Young; Kim, Soo Cheol; Park, Yong Koo; Kim, Youn Wha.

In: Pathology Research and Practice, Vol. 208, No. 5, 15.05.2012, p. 292-299.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma

AU - Kim, Hyunsoo

AU - Won, Kyu Yeoun

AU - Kim, Gou Young

AU - Kim, Soo Cheol

AU - Park, Yong Koo

AU - Kim, Youn Wha

PY - 2012/5/15

Y1 - 2012/5/15

N2 - Raf-1 kinase inhibitory protein (RKIP), a suppressor of metastasis, is associated inversely with the progression and metastasis of human malignancies. The present study evaluated relationships between RKIP expression and metastatic potential, clinicopathological characteristics and patient outcome in esophageal squamous cell carcinoma (ESCC). We examined tissue specimens from 138 patients with thoracic ESCC. Using immunohistochemistry, RKIP expression was detected in ESCC . in situ, primary ESCC and nodal metastatic ESCC. RKIP expression was reduced in 28.9% (13/45) of ESCC . in situ, in 50.0% (69/138) of primary ESCC and in 71.4% (65/91) of nodal metastatic ESCC. These levels of RKIP down-regulation differed significantly. RKIP expression was associated inversely with histological grade (. P=. 0.008), pathological T stage (. P=. 0.044), lymphatic invasion (. P=. 0.019), regional lymph node metastasis (LNM; . P=. 0.002) and stage (. P=. 0.041). Pathological T stage (. P=. 0.001), lymphatic invasion (. P<. 0.001) and reduced RKIP expression (. P=. 0.039) were independent predictors of regional LNM in ESCC. In addition, the postoperative survival of patients with RKIP-reduced ESCC was significantly shorter than for patients with RKIP-positive ESCC (. P=. 0.004). Reduced RKIP expression in ESCC correlated with advanced disease, regional LNM and poor prognosis. RKIP expression may serve as a novel clinical biomarker in patients with ESCC.

AB - Raf-1 kinase inhibitory protein (RKIP), a suppressor of metastasis, is associated inversely with the progression and metastasis of human malignancies. The present study evaluated relationships between RKIP expression and metastatic potential, clinicopathological characteristics and patient outcome in esophageal squamous cell carcinoma (ESCC). We examined tissue specimens from 138 patients with thoracic ESCC. Using immunohistochemistry, RKIP expression was detected in ESCC . in situ, primary ESCC and nodal metastatic ESCC. RKIP expression was reduced in 28.9% (13/45) of ESCC . in situ, in 50.0% (69/138) of primary ESCC and in 71.4% (65/91) of nodal metastatic ESCC. These levels of RKIP down-regulation differed significantly. RKIP expression was associated inversely with histological grade (. P=. 0.008), pathological T stage (. P=. 0.044), lymphatic invasion (. P=. 0.019), regional lymph node metastasis (LNM; . P=. 0.002) and stage (. P=. 0.041). Pathological T stage (. P=. 0.001), lymphatic invasion (. P<. 0.001) and reduced RKIP expression (. P=. 0.039) were independent predictors of regional LNM in ESCC. In addition, the postoperative survival of patients with RKIP-reduced ESCC was significantly shorter than for patients with RKIP-positive ESCC (. P=. 0.004). Reduced RKIP expression in ESCC correlated with advanced disease, regional LNM and poor prognosis. RKIP expression may serve as a novel clinical biomarker in patients with ESCC.

UR - http://www.scopus.com/inward/record.url?scp=84862799037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862799037&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2012.02.011

DO - 10.1016/j.prp.2012.02.011

M3 - Article

VL - 208

SP - 292

EP - 299

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 5

ER -